Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pierre Fabre Pharma Norden AB
AB
Active
Org 5565179305
Karlavägen 108, 115 26
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1995
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pierre Fabre Pharma Norden AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PV
Poul Valdemar Planeta
Authorized Recipient of Service
Authorized Recipient of Service
2023
LM
Leif Magnus Holmgren
Chief Auditor
Chief Auditor
2022
Former (3)
EO
Erik Oskar Wall
Chief Auditor
Chief Auditor
2021 – 2022
AH
Aki Henrikki Liikola
Chief Executive Officer
Chief Executive Officer
2020 – 2023
SD
Stig Daniel Öberg
Chief Auditor
Chief Auditor
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
MJ
Marek Jerry Czarnecki
Chairman
2026
LC
Linda Carine Tibbits
Chairman
2025
PL
Pierre-Emmanuel Liraud
Deputy Board Member
2023
AH
Alan Hervé Peyon
Board of Directors
2025
Former (3)
GA
Guillaume Alain Tamet
Deputy Board Member
2020 – 2023
VH
Vincent Henri Francois Guiraud-Chaumeil
Chairman
2020 – 2020
FC
Fabrice Claude Clair Delabarre
Chairman
2020 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
PIERRE FABRE MEDICAMENT S.A.S
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Pierre Fabre Pharma Norden AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
